GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (NAS:ALGN) » Definitions » Cyclically Adjusted PS Ratio

ALGN (Align Technology) Cyclically Adjusted PS Ratio : 4.57 (As of Jun. 15, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Align Technology Cyclically Adjusted PS Ratio?

As of today (2025-06-15), Align Technology's current share price is $177.85. Align Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $38.90. Align Technology's Cyclically Adjusted PS Ratio for today is 4.57.

The historical rank and industry rank for Align Technology's Cyclically Adjusted PS Ratio or its related term are showing as below:

ALGN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.95   Med: 13.93   Max: 38.66
Current: 4.57

During the past years, Align Technology's highest Cyclically Adjusted PS Ratio was 38.66. The lowest was 3.95. And the median was 13.93.

ALGN's Cyclically Adjusted PS Ratio is ranked worse than
67.78% of 481 companies
in the Medical Devices & Instruments industry
Industry Median: 2.24 vs ALGN: 4.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Align Technology's adjusted revenue per share data for the three months ended in Mar. 2025 was $13.302. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $38.90 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Align Technology Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Align Technology's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology Cyclically Adjusted PS Ratio Chart

Align Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.27 29.79 7.69 8.47 5.58

Align Technology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.65 6.85 7.00 5.58 4.08

Competitive Comparison of Align Technology's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Align Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Align Technology's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Align Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Align Technology's Cyclically Adjusted PS Ratio falls into.


;
;

Align Technology Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Align Technology's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=177.85/38.90
=4.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Align Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Align Technology's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=13.302/134.9266*134.9266
=13.302

Current CPI (Mar. 2025) = 134.9266.

Align Technology Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.574 100.684 3.449
201509 2.560 100.392 3.441
201512 2.830 99.792 3.826
201603 2.936 100.470 3.943
201606 3.314 101.688 4.397
201609 3.420 101.861 4.530
201612 3.603 101.863 4.773
201703 3.806 102.862 4.992
201706 4.367 103.349 5.701
201709 4.710 104.136 6.103
201712 5.135 104.011 6.661
201803 5.353 105.290 6.860
201806 6.018 106.317 7.637
201809 6.211 106.507 7.868
201812 6.608 105.998 8.411
201903 6.804 107.251 8.560
201906 7.454 108.070 9.306
201909 7.608 108.329 9.476
201912 8.203 108.420 10.208
202003 6.972 108.902 8.638
202006 4.473 108.767 5.549
202009 9.274 109.815 11.395
202012 10.473 109.897 12.858
202103 11.213 111.754 13.538
202106 12.693 114.631 14.940
202109 12.776 115.734 14.895
202112 12.946 117.630 14.850
202203 12.289 121.301 13.669
202206 12.344 125.017 13.322
202209 11.380 125.227 12.261
202212 11.599 125.222 12.498
202303 12.231 127.348 12.959
202306 13.068 128.729 13.697
202309 12.499 129.860 12.987
202312 12.634 129.419 13.172
202403 13.242 131.776 13.559
202406 13.673 132.554 13.918
202409 13.081 133.029 13.268
202412 13.354 133.157 13.531
202503 13.302 134.927 13.302

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Align Technology  (NAS:ALGN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Align Technology Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Align Technology's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Align Technology Business Description

Address
410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Executives
Larkin C Raymond Jr director C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Joseph Lacob director 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Emory Wright officer: VP, Operations C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Joseph M Hogan director, officer: President and CEO C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Kevin J Dallas director C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134
John Morici officer: Chief Financial Officer C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Warren S Thaler director C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Anne Myong director 2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Julie Ann Coletti officer: SVP, Chief Legal & Regulatory 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Greg J Santora director 4201 GRANT COURT, PLEASANTON CA 94566
Stuart A Hockridge officer: VP, Global Human Resources C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
George J Morrow director AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Andrea Lynn Saia director C/O COCA-COLA ENTERPRISES, INC., 2500 WINDY RIDGE PARKWAY, NW, 14TH FLOOR, ATLANTA GA 30339
Thomas M Prescott director C/O ALIGN TECHNOLOGY INC, 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked officer: SVP and Mgng Director, Itero C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134